LL-37 is the only human cathelicidin antimicrobial peptide and is studied in immune and antimicrobial research. This page is an educational overview. telos rx does not offer or prescribe LL-37.
What Is LL-37?
LL-37 is a 37-amino-acid peptide derived from human cathelicidin. It is studied in preclinical research for antimicrobial and immune-modulating pathways.
LL-37 is not an FDA-approved drug.
Where LL-37 Shows Up in Research
LL-37 comes up most often in research on:
- Antimicrobial pathways
- Immune modulation
- Skin and barrier function
- Inflammation
Most of this work is laboratory and animal research, so the human evidence is limited.
Regulatory Context
LL-37 is not FDA-approved. It was not among the peptides reviewed by the FDA's Pharmacy Compounding Advisory Committee in July 2026, and it is not covered by the interim enforcement discretion policy HHS announced on October 28, 2026, which applies only to BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500.
Does telos rx Offer LL-37?
No. telos rx does not offer, prescribe or ship LL-37.
Important Information
LL-37 is not FDA-approved. This article is for education only and is not medical advice.
Want to read more? Browse our Peptide Research blog.